Nanjing Vazyme Biotech

Nanjing Vazyme Biotech is one of the...

• CSI 500.

Nanjing Vazyme Biotech is a company listed under the stock ticker 688105 (CN).

View the org chart displaying its 1 main executives

Most searched biographies at Nanjing Vazyme Biotech

• Lin Cao, Chairman of the Board and General Manager

Create your alert
to follow the executive moves at Nanjing Vazyme Biotech.

Nanjing Vazyme Biotech has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Nanjing Vazyme Biotech

• Company News Manufacturers & Suppliers - Company News Factory
• Gene Expression Analysis Manufacturer and Supplier, Factory, Products | Vazyme
• News

Social media about Nanjing Vazyme Biotech

• Nanjing Vazyme Biotech on Wikipedia, Google News & Yahoo Finance
• Nanjing Vazyme Biotech on LinkedIn, Twitter & YouTube

Call Nanjing Vazyme Biotech at +86 258...

View the org chart

Register to receive your alert

Report an error